| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3992514 | Journal of Thoracic Oncology | 2006 | 6 Pages |
Abstract
Gender and smoking status were not, but good performance status (PS), no previous chemotherapy, and adenocarcinoma histology were independent predictive factors in multivariate analysis for gefitinib response in Taiwanese advanced non-small cell lung cancer population. In patients previously treated with chemotherapy, only good PS was an independent predictor for tumor response in multivariate analysis.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Gee-Chen MD, PhD, Chun-Ming MD, Kun-Chieh MD, Chong-Jen MD, PhD, Jin-Yuan MD, PhD, Tsung-Ying MD, Ching-Pei RN, Jeng-Yuan MD, Chao-Hua MD, Reury-Perng MD, PhD, Pan-Chyr MD, PhD, Chih-Hsin MD, PhD,